Related Experiment Video
Updated: Apr 5, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Perioperative anticoagulant management in patients with atrial fibrillation : practical implications of recent
Insights
Managing anticoagulation for atrial fibrillation patients undergoing procedures is complex. Recent trials inform best practices for perioperative anticoagulation, guiding decisions on interruption and bridging therapy to minimize risks.
Area of Science:
- Cardiology
- Pharmacology
- Neurosurgery
Background:
- Perioperative anticoagulation management for patients on chronic anticoagulant therapy, particularly those with atrial fibrillation (AF), presents a significant clinical challenge.
- Atrial fibrillation is the most common indication for long-term anticoagulation, necessitating careful management during surgical or invasive procedures.
- Balancing the risk of thromboembolism against bleeding complications is crucial for patient safety.
Purpose of the Study:
- To summarize recent clinical trial findings relevant to perioperative anticoagulation management in AF patients.
- To provide an evidence-based algorithmic approach for managing anticoagulation in patients undergoing procedures.
- To address key questions regarding the necessity of anticoagulation interruption, risk assessment for thromboembolism and bleeding, and the need for bridging therapy.
Main Methods:
- A case-based review format was employed.
- Evidence from recent clinical trials was synthesized to inform best practices.
- The study explored three core questions: necessity of anticoagulation interruption, risk stratification for thromboembolic and bleeding events, and indications for bridging anticoagulation.
Main Results:
- Recent clinical trials have provided valuable insights into optimizing perioperative anticoagulation strategies.
- A framework for assessing individual patient risks for thromboembolism and bleeding has been developed.
- Guidelines for deciding whether to interrupt anticoagulation and when bridging therapy is indicated have been informed by current evidence.
Conclusions:
- A structured, evidence-based approach is essential for safe perioperative anticoagulation management in AF patients.
- The decision to interrupt anticoagulation and use bridging therapy should be guided by a careful assessment of procedural risk and patient-specific factors.
- An algorithmic approach can help clinicians navigate the complexities of managing anticoagulation during the perioperative period.
Abstract:
Defining the safest perioperative anticoagulation management approach for patients who are receiving chronic anticoagulant therapy stroke prevention has been a challenging and longstanding dilemma, especially for patients with atrial fibrillation who constitute the most common patient group receiving long term anticoagulation. Using a case-based format, we summarize the findings of recent clinical trialswhich have helped to informed best practices for perioperative anticoagulant management in patients with atrial fibrillation and provide an algorithmic management approach to this problem. We have done so by exploring the evidence to address 3 key questions: Is it necessary to interrupt anticoagulation for a procedure? How to estimate a patient's risk for perioperative thromboembolism and bleeding? If chronic anticoagulation interruption is required, is bridging anticoagulation with heparin needed?
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Aneurysm IV: Nursing Management
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Venous Thrombosis IV: Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management

